Breast Cancer FRT RNA seq
We propose to definitively characterise the somatic genetics of ER+ve, HER2-ve breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
- Technology: Illumina HiSeq 2000
- 3 samples
- DAC: EGAC00001000000
- Data Use Conditions:
- IS DUO:0000028 (version: 2021-02-23) institution specific restriction This data use modifier indicates that use is limited to use within an approved institution.
- US DUO:0000026 (version: 2021-02-23) user specific restriction This data use modifier indicates that use is limited to use by approved users.
- GRU DUO:0000042 (version: 2021-02-23) general research use This data use permission indicates that use is allowed for general research use for any research purpose.
- PUB DUO:0000019 (version: 2021-02-23) publication required This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.
|Study ID||Study Title||Study Type|